Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Zydus Lifesciences
Pharmaceutical Preparation ManufacturingIndiaNSE: ZYDUSLIFE.NS
Last verified 6 months agozyduslife.com
Zydus Lifesciences, widely recognised as Zydus, is a prominent global pharmaceutical company with its headquarters situated in Ahmedabad, India. Established in 1952, it has evolved into a key player in the Pharmaceutical Preparation Manufacturing industry, dedicated to pioneering healthcare solutions.
The company excels in the research, development, manufacturing, and marketing of a diverse portfolio, including innovative pharmaceutical products, active pharmaceutical ingredients (APIs), and consumer wellness offerings. Zydus focuses on delivering accessible and affordable medicines across various therapeutic segments, improving lives globally.
With a robust presence in India and an expanding international footprint, Zydus Lifesciences consistently demonstrates its commitment to quality and innovation. This strategic approach reinforces its position as a leading name in the global pharmaceutical landscape.
46
DitchCarbon score
+4 vs industry average
Zydus Lifesciences’s score of 46 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Zydus Lifesciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2029
2020202120222023202420252026202720282029
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Zydus Lifesciences's reported carbon emissions
Zydus Lifesciences: Climate Commitments and Emissions Performance
Zydus Lifesciences, a Pharmaceutical Preparation Manufacturing company headquartered in India, is committed to addressing its carbon footprint and has set ambitious climate targets.
Emissions Data:
The company has reported its greenhouse gas emissions, with projections for future years:
- 2026 (Projected): Zydus Lifesciences projects its Scope 1 emissions to be approximately 67,528,000 kg CO2e and its Scope 3 emissions to be about 1,310,180,000 kg CO2e. Scope 2 data was not provided for this year.
- 2025 (Projected): The company projects Scope 1 emissions of approximately 56,459,000 kg CO2e and Scope 3 emissions of about 1,300,997,000 kg CO2e. Scope 2 data was not provided.
- 2024 (Reported): Zydus Lifesciences reported Scope 1 emissions of approximately 65,458,740 kg CO2e, Scope 2 emissions of about 192,010,230 kg CO2e, and Scope 3 emissions of approximately 51,363,480 kg CO2e.
- 2023 (Reported): The company reported Scope 1 emissions of approximately 56,053,320 kg CO2e, Scope 2 emissions of about 223,014,700 kg CO2e, and Scope 3 emissions of approximately 25,670,000 kg CO2e.
- 2022 (Reported): Zydus Lifesciences reported total emissions of approximately 259,815,000 kg CO2e. This included Scope 1 emissions of around 59,573,000 kg CO2e, Scope 2 emissions of about 191,170,000 kg CO2e, and Scope 3 emissions of approximately 9,072,000 kg CO2e.
- 2021 (Reported): The company reported Scope 1 emissions of approximately 83,789,000 kg CO2e and Scope 2 emissions of about 162,104,000 kg CO2e. Scope 3 data was not provided for this year.
- 2020 (Reported): Zydus Lifesciences reported Scope 1 emissions of approximately 92,070,000 kg CO2e and Scope 2 emissions of about 168,794,000 kg CO2e. Scope 3 data was not provided for this year.
Climate Commitments:
Zydus Lifesciences is a signatory to the Science Based Targets initiative (SBTi), having committed to setting near-term and net-zero targets. The company has publicly committed to achieving carbon neutrality in its operations (covering Scope 1 and Scope 2 emissions) by FY2035. This long-term commitment demonstrates a clear pathway towards decarbonisation within its operational boundaries.
Assessing Zydus Lifesciences as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Zydus Lifesciences and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Zydus Lifesciences’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Zydus Lifesciences6 months ago
46
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Zydus Lifesciences’s sustainability data and climate commitments
For 2026, Zydus Lifesciences projects its Scope 1 emissions to be approximately 67,528,000 kg CO2e and its Scope 3 emissions to be about 1,310,180,000 kg CO2e. Scope 2 data was not provided for this projected year. These figures indicate a significant contribution from Scope 3 activities, which often encompass the broader value chain impacts for companies in the pharmaceutical preparation manufacturing sector. Understanding these projected figures is crucial for assessing the company's progress towards its climate commitments.
Data year: 2026
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more